SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-028173
Filing Date
2021-04-23
Accepted
2021-04-23 17:33:03
Documents
2
Period of Report
2021-04-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1529
2 POA DOCUMENT poa.txt EX-24.3_980675 3631
  Complete submission text file 0001209191-21-028173.txt   6588
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Issuer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O MYOVANT SCIENCES INC. 2000 SIERRA POINT PARKWAY BRISBANE CA 94005
Business Address
Sablich Kim (Reporting) CIK: 0001758790 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36183 | Film No.: 21850819